|
C15ORF29 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.327800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.228200E-01 |
| Normal-vs-Stage2 |
6.524400E-01 |
| Normal-vs-Stage3 |
5.293000E-01 |
| Normal-vs-Stage4 |
3.597400E-01 |
| Stage1-vs-Stage2 |
7.085400E-01 |
| Stage1-vs-Stage3 |
4.527200E-01 |
| Stage1-vs-Stage4 |
4.237200E-01 |
| Stage2-vs-Stage3 |
4.232800E-01 |
| Stage2-vs-Stage4 |
4.657000E-01 |
| Stage3-vs-Stage4 |
9.383800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.558800E-01 |
| Normal-vs-AfricanAmerican |
2.272200E-01 |
| Normal-vs-Asian |
6.476400E-01 |
| Caucasian-vs-AfricanAmerican |
2.639800E-01 |
| Caucasian-vs-Asian |
2.815200E-01 |
| AfricanAmerican-vs-Asian |
8.355600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.194400E-01 |
| Normal-vs-Female |
2.164000E-01 |
| Male-vs-Female |
2.227400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.616000E-01 |
| Normal-vs-Extreme_Weight |
6.475600E-01 |
| Normal-vs-Obese |
8.113000E-01 |
| Normal-vs-Extreme_Obese |
9.541000E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.943400E-01 |
| Normal_Weight-vs-Obese |
9.506400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.310200E-01 |
| Extreme_Weight-vs-Obese |
5.468400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.789800E-01 |
| Obese-vs-Extreme_Obese |
8.714600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.647000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.161420E-01 |
| Normal-vs-Age(61-80Yrs) |
9.889800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.012000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.222600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.246400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.969800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.042200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.439800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.223600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.868300E-02 |
| Normal-VS-Type2 PRCC |
1.800300E-03 |
| Normal-VS-KIRP CIMP |
6.219600E-01 |
| Normal-VS-Unclassified PRCC |
8.160600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.57390000424351E-08 |
| Type1 PRCC-VS-KIRP CIMP |
9.334800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.029190E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.561200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.211900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.811400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.236400E-02 |
| Normal-vs-N1 |
7.521600E-01 |
| Normal-vs-N2 |
2.384400E-03 |
| N0-vs-N1 |
2.322600E-01 |
| N0-vs-N2 |
9.433500E-02 |
| N1-vs-N2 |
8.601400E-03 |
|
|
